Merck Serono and Kadimastem Sign MOU on Drug Screening and Discovery for Neurodegenerative Diseases

–  Yossi Ben-Yossef, CEO and Founder of Kadimastem German global pharmaceutical company Merck Serono, and Israeli Kadimastem (TASE:KDST) , a developer of human pluripotent stem cell-based More...